Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients
Abstract
:1. Introduction
2. Results
2.1. The Endoscopic Evaluation, Colon Length Measurement, Spleen Weight and DAI Score Showed That Ade/HA Intrarectal Administration Ameliorated Both the Acute and Post-Remission Phase of DNBS-Induced Colitis
2.2. Intrarectal Ade/HA Administration Reduced ZO-1 and Occludin Loss Induced by DNBS in Both Acute and Remission Phase of Colitis
2.3. Intrarectal Ade/HA Administration Reduced DNBS-Induced Proinflammatory Response, Oxidative Stress and Endotoxemia without Affecting Endogenous PEA Level and in Absence of Systemic Adelmidrol Absorption
2.4. Ade/HA Inhibited Cytomix-Induced Pro-Inflammatory Response in Cultured Human UC-Deriving Biopsies without Interfering with in Ex-Vivo PEA Production
3. Discussion
4. Materials and Methods
4.1. Animals and Experimental Design
4.2. Patients and Tissue Culture Treatments
4.3. Endoscopic Procedures in Mouse and Endoscopic Damage Score Evaluation
4.4. Colon Length, Spleen Weight and Disease Activity Index (DAI)
4.5. Histopathological Analysis of the Mouse and Human Ex Vivo Cultured Colonic Biopsies
4.6. Macrophage Infiltration Immunohistochemical Assay
4.7. In Vivo Assay of the Intestinal Permeability
4.8. Zonula Occludens (ZO-1) and Occludin Immunofluorescence
4.9. Protein Extraction and ZO-1 and Occludin Immunoblot Analysis
4.10. Plasma Collection and Adelmidrol Quantification in the Blood
4.11. ELISA Quantification of LPS (Endotoxemia), IL-1β, IL-6, and TNF-α in the Mouse Plasma and Human Bioptic Samples
4.12. Myeloperoxidase Activity
4.13. Lipid Peroxidation Assay
4.14. PEA Level Quantification
4.15. Statistical Analysis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gecse, K.B.; Vermeire, S. Differential diagnosis of inflammatory bowel disease: Imitations and complications. Lancet Gastroenterol. Hepatol. 2018, 3, 644–653. [Google Scholar] [CrossRef] [PubMed]
- Ananthakrishnan, A.N.; Bernstein, C.N.; Iliopoulos, D.; Macpherson, A.; Neurath, M.F.; Ali, R.A.R.; Vavricka, S.R.; Fiocchi, C. Environmental triggers in IBD: A review of progress and evidence. Nat. Rev. Gastroenterol. Hepatol. 2018, 15, 39–49. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.Z.; Li, Y.Y. Inflammatory bowel disease: Pathogenesis. World J. Gastroenterol. 2014, 20, 91–99. [Google Scholar] [CrossRef] [PubMed]
- De Felice, K.M. Patients Perception of Risks and Benefits of Biologic Therapy. Inflamm. Bowel Dis. 2020, 26, 147–149. [Google Scholar] [CrossRef] [PubMed]
- Siegel, C.A. Review article: Explaining risks of inflammatory bowel disease therapy to patients. Aliment. Pharmacol. Ther. 2011, 33, 23–32. [Google Scholar] [CrossRef] [PubMed]
- Fusco, R.; Cordaro, M.; Genovese, T.; Impellizzeri, D.; Siracusa, R.; Gugliandolo, E.; Peritore, A.F.; D’Amico, R.; Crupi, R.; Cuzzocrea, S.; et al. Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis. Antioxidants 2020, 9, 601. [Google Scholar] [CrossRef]
- Cordaro, M.; Impellizzeri, D.; Gugliandolo, E.; Siracusa, R.; Crupi, R.; Esposito, E.; Cuzzocrea, S. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease. Mol. Pharmacol. 2016, 90, 549–561. [Google Scholar] [CrossRef]
- Petrosino, S.; Puigdemont, A.; Della Valle, M.F.; Fusco, M.; Verde, R.; Allarà, M.; Aveta, T.; Orlando, P.; Di Marzo, V. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. Vet. J. 2016, 207, 85–91. [Google Scholar] [CrossRef]
- Del Re, A.; Palenca, I.; Seguella, L.; Pesce, M.; Corpetti, C.; Steardo, L.; Rurgo, S.; Sarnelli, G.; Esposito, G. Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action. Metabolites 2022, 12, 457. [Google Scholar] [CrossRef]
- Volpi, N.; Schiller, J.; Stern, R.; Soltés, L. Role, metabolism, chemical modifications and applications of hyaluronan. Curr. Med. Chem. 2009, 16, 1718–1745. [Google Scholar] [CrossRef]
- Di Paola, R.; Fusco, R.; Impellizzeri, D.; Cordaro, M.; Britti, D.; Morittu, V.M.; Evangelista, M.; Cuzzocrea, S. Adelmidrol, in combination with hyaluronic acid, displays increased anti-inflammatory and analgesic effects against monosodium iodoacetate-induced osteoarthritis in rats. Arthritis Res. Ther. 2016, 18, 291. [Google Scholar] [CrossRef] [PubMed]
- Campolo, M.; Siracusa, R.; Cordaro, M.; Filippone, A.; Gugliandolo, E.; Peritore, A.F.; Impellizzeri, D.; Crupi, R.; Paterniti, I.; Cuzzocrea, S. The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice. PLoS ONE 2019, 14, e0208730. [Google Scholar] [CrossRef]
- Ostardo, E.; Impellizzeri, D.; Cervigni, M.; Porru, D.; Sommariva, M.; Cordaro, M.; Siracusa, R.; Fusco, R.; Gugliandolo, E.; Crupi, R.; et al. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study. Pharmacol. Res. 2018, 134, 16–30. [Google Scholar] [CrossRef] [PubMed]
- Fiocchi, C.; Iliopoulos, D. Numbers Do Not Lie: The Dire Need for New Directions in IBD. J. Crohns Colitis 2022, 16, 1649–1650. [Google Scholar] [CrossRef] [PubMed]
- De Filippis, D.; D’Amico, A.; Cinelli, M.P.; Esposito, G.; Di Marzo, V.; Iuvone, T. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. J. Cell. Mol. Med. 2009, 13, 1086–1095. [Google Scholar] [CrossRef]
- Impellizzeri, D.; Di Paola, R.; Cordaro, M.; Gugliandolo, E.; Casili, G.; Morittu, V.M.; Britti, D.; Esposito, E.; Cuzzocrea, S. Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation. Biochem. Pharmacol. 2016, 119, 27–41. [Google Scholar] [CrossRef]
- Mak, W.Y.; Zhao, M.; Ng, S.C.; Burisch, J. The epidemiology of inflammatory bowel disease: East meets west. J. Gastroenterol. Hepatol. 2020, 35, 380–389. [Google Scholar] [CrossRef]
- Casili, G.; Cordaro, M.; Impellizzeri, D.; Bruschetta, G.; Paterniti, I.; Cuzzocrea, S.; Esposito, E. Dimethyl Fumarate Reduces Inflammatory Responses in Experimental Colitis. J. Crohns Colitis 2016, 10, 472–483. [Google Scholar] [CrossRef]
- Liu, W.; Liu, Y.Y.; Zhang, M.Q.; Qin, M.Z.; Yang, Y.Y.; Liu, B.W.; Zhang, D.J.; Jiang, C.H.; Yin, Z.Q.; Lu, M.; et al. A comparative study of the ameliorative effects of hyaluronic acid oligosaccharides and hyaluronic acid on DSS-induced colitis in mice and research on relevant mechanisms. Food Funct. 2023, 14, 6482–6495. [Google Scholar] [CrossRef]
- Jhundoo, H.D.; Siefen, T.; Liang, A.; Schmidt, C.; Lokhnauth, J.; Moulari, B.; Béduneau, A.; Pellequer, Y.; Larsen, C.C.; Lamprecht, A. Hyaluronic Acid Increases Anti-Inflammatory Efficacy of Rectal 5-Amino Salicylic Acid Administration in a Murine Colitis Model. Biomol. Ther. 2021, 29, 536–544. [Google Scholar] [CrossRef]
- Hlaing, S.P.; Cao, J.; Lee, J.; Kim, J.; Saparbayeva, A.; Kwak, D.; Kim, H.; Hwang, S.; Yun, H.; Moon, H.R.; et al. Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages. Pharmaceutics 2022, 14, 2118. [Google Scholar] [CrossRef] [PubMed]
- Weber, G.C.; Buhren, B.A.; Schrumpf, H.; Wohlrab, J.; Gerber, P.A. Clinical Applications of Hyaluronidase. Adv. Exp. Med. Biol. 2019, 1148, 255–277. [Google Scholar] [CrossRef] [PubMed]
- Naganuma, M.; Iwao, Y.; Ogata, H.; Inoue, N.; Funakoshi, S.; Yamamoto, S.; Nakamura, Y.; Ishii, H.; Hibi, T. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: Comparison of orally administered mesalamine and sulfasalazine. Inflamm. Bowel Dis. 2001, 7, 221–225. [Google Scholar] [CrossRef] [PubMed]
- Wirtz, S.; Neufert, C.; Weigmann, B.; Neurath, M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007, 2, 541–546. [Google Scholar] [CrossRef] [PubMed]
- Seguella, L.; Rinaldi, F.; Marianecci, C.; Capuano, R.; Pesce, M.; Annunziata, G.; Casano, F.; Bassotti, G.; Sidoni, A.; Milone, M.; et al. Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue. J. Cell. Mol. Med. 2020, 24, 3053–3063. [Google Scholar] [CrossRef]
- De Palma, G.D.; Colavita, I.; Zambrano, G.; Giglio, M.C.; Maione, F.; Luglio, G.; Sarnelli, G.; Rispo, A.; Schettino, P.; D’Armiento, F.P.; et al. Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study. PLoS ONE 2017, 12, e0180509. [Google Scholar] [CrossRef]
- Coëffier, M.; Miralles-Barrachina, O.; Le Pessot, F.; Lalaude, O.; Daveau, M.; Lavoinne, A.; Eric Lerebours, E.; Déchelotte, P. Influence of glutamine on cytokine production by human gut in vitro. Cytokine 2001, 13, 148–154. [Google Scholar] [CrossRef]
- Cirillo, C.; Sarnelli, G.; Esposito, G.; Grosso, M.; Petruzzelli, R.; Izzo, P.; Calì, G.; D’Armiento, F.P.; Rocco, A.; Nardone, G.; et al. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol. Motil. 2009, 21, 1209-e112. [Google Scholar] [CrossRef]
- Becker, C.; Fantini, M.C.; Neurath, M.F. High resolution colonoscopy in live mice. Nat. Protoc. 2006, 1, 2900–2904. [Google Scholar] [CrossRef]
- Cooper, H.S.; Murthy, S.N.; Shah, R.S.; Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Investig. 1993, 69, 238–249. [Google Scholar]
- Li, R.; Kim, M.-H.; Sandhu, A.K.; Gao, C.; Gu, L. Muscadine Grape (Vitis rotundifolia) or Wine Phytochemicals Reduce Intestinal Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis. J. Agric. Food Chem. 2017, 65, 769–776. [Google Scholar] [CrossRef] [PubMed]
- Thoree, V.; Skepper, J.; Deere, H.; Pele, L.C.; Thompson, R.P.H.; Powell, J.J. Phenotype of exogenous microparticle-containing pigment cells of the human Peyer’s patch in inflamed and normal ileum. Inflamm. Res. 2008, 57, 374–378. [Google Scholar] [CrossRef] [PubMed]
- D’Amico, R.; Siracusa, R.; Fusco, R.; Cordaro, M.; Genovese, T.; Peritore, A.F.; Gugliandolo, E.; Crupi, R.; Impellizzeri, D.; Cuzzocrea, S.; et al. Protective effects of Colomast®, A New Formulation of Adelmidrol and Sodium Hyaluronate, in A Mouse Model of Acute Restraint Stress. Int. J. Mol. Sci. 2020, 21, 8136. [Google Scholar] [CrossRef] [PubMed]
- Cassini-Vieira, P.; Moreira, C.F.; da Silva, M.F.; da Silva Barcelos, L. Estimation of Wound Tissue Neutrophil and Macrophage Accumulation by Measuring Myeloperoxidase (MPO) and N-Acetyl-β-D-glucosaminidase (NAG) Activities. Bio-Protocol 2015, 5, e1662. [Google Scholar] [CrossRef]
- Esposito, G.; Capoccia, E.; Sarnelli, G.; Scuderi, C.; Cirillo, C.; Cuomo, R.; Steardo, L. The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice. J. Neuroinflammation 2012, 9, 277. [Google Scholar] [CrossRef]
- Gachet, M.S.; Rhyn, P.; Bosch, O.G.; Quednow, B.B.; Gertsch, J. A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. J. Chromatogr. B 2015, 976–977, 6–18. [Google Scholar] [CrossRef]
Time (Hours after Intrarectal Administration) | Level of Quantification (LOQ) [ng/mL] in the Plasma |
---|---|
0 | <71.4 |
72 | <71.4 |
168 | <71.4 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Palenca, I.; Seguella, L.; Zilli, A.; Basili Franzin, S.; Del Re, A.; Pepi, F.; Troiani, A.; Pesce, M.; Rurgo, S.; De Palma, F.D.E.; et al. Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients. Int. J. Mol. Sci. 2024, 25, 165. https://doi.org/10.3390/ijms25010165
Palenca I, Seguella L, Zilli A, Basili Franzin S, Del Re A, Pepi F, Troiani A, Pesce M, Rurgo S, De Palma FDE, et al. Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients. International Journal of Molecular Sciences. 2024; 25(1):165. https://doi.org/10.3390/ijms25010165
Chicago/Turabian StylePalenca, Irene, Luisa Seguella, Aurora Zilli, Silvia Basili Franzin, Alessandro Del Re, Federico Pepi, Anna Troiani, Marcella Pesce, Sara Rurgo, Fatima Domenica Elisa De Palma, and et al. 2024. "Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients" International Journal of Molecular Sciences 25, no. 1: 165. https://doi.org/10.3390/ijms25010165